Premium
P4‐334: Neuroprotective and synaptogenic actions of PI3K in an Alzheimer's model in Drosophila
Author(s) -
Arnes Mercedes,
Acebes Angel,
Ferrus Alberto
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.09.079
Subject(s) - drosophila melanogaster , neuroscience , context (archaeology) , neuroprotection , biology , synaptogenesis , anosmia , pi3k/akt/mtor pathway , drosophila (subgenus) , genetic model , olfactory system , phenotype , neurodegeneration , disease , genetics , medicine , signal transduction , gene , paleontology , covid-19 , infectious disease (medical specialty)
Further analyses will make use of the data assessed to find mediating factors on the course of the disease. An analysis will cover the detection and intervention against clinically relevant interaction and other drug related problems. Conclusions: The DelpHi-MV study is the first population-based intervention trial for peoplewith dementia in the primary care setting in Germany. First results of the pre-test already have shown where adaptations in the study design are needed.